Neurofilament functions in health and disease

Transgenic approaches have recently been used to investigate the functions of neuronal intermediate filaments. Gene knockout studies have demonstrated that neurofilaments are not required for axogenesis and that individual neurofilament proteins play distinct roles in filament assembly and in the radial growth of axons. The involvement of neurofilaments in disease is supported by the discovery of novel mutations in the neurofilament heavy gene from cases of amyotrophic lateral sclerosis and by reports of neuronal death in mouse models expressing neurofilament and alpha-internexin transgenes. However, mouse studies have shown that axonal neurofilaments are not required for pathogenesis caused by mutations in superoxide dismutase and that increasing perikaryal levels of neurofilament proteins may even confer protection in this disease.

[1]  J. Julien,et al.  Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis , 1995, Nature.

[2]  Q. Zhu,et al.  Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  N. Hirokawa,et al.  Dynamics of the neuronal intermediate filaments , 1993, The Journal of cell biology.

[4]  J. Priestley,et al.  Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. , 1999, Diabetes.

[5]  M. Gurney,et al.  Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[6]  Anthony Brown,et al.  Slow Axonal Transport of Neurofilament Protein in Cultured Neurons , 1999, The Journal of cell biology.

[7]  J. Trojanowski,et al.  Neurofilaments and Orthograde Transport Are Reduced in Ventral Root Axons of Transgenic Mice that Express Human SOD1 with a G93A Mutation , 1997, The Journal of cell biology.

[8]  P. Bosco,et al.  Absence of the Mid-sized Neurofilament Subunit Decreases Axonal Calibers, Levels of Light Neurofilament (NF-L), and Neurofilament Content , 1998, The Journal of cell biology.

[9]  S. Barnes,et al.  Superoxide Dismutase Catalyzes Nitration of Tyrosines by Peroxynitrite in the Rod and Head Domains of Neurofilament‐L , 1997, Journal of neurochemistry.

[10]  P. H. Spencer,et al.  The pathway of assembly of intermediate filaments from recombinant alpha-internexin. , 1998, Journal of structural biology.

[11]  L. WilliamsonT,et al.  神経フィラメントの欠如は,家族性筋萎縮性側索硬化症関連スーパオキジドジスムターゼ1変異に対する運動ニューロンの選択的易損性を低下させ,疾患を遅らせる , 1998 .

[12]  P. Wong,et al.  Pathogenesis of two axonopathies does not require axonal neurofilaments , 1998, Nature.

[13]  V. Tung,et al.  Antagonistic Roles of Neurofilament Subunits NF-H and NF-M Against NF-L in Shaping Dendritic Arborization in Spinal Motor Neurons , 1998, The Journal of cell biology.

[14]  Guy A. Rouleau,et al.  SOD1 mutation is assosiated with accumulation of neurofilaments in amyotrophic lateral scelaries , 1996 .

[15]  J W Griffin,et al.  Neurofilament gene expression: a major determinant of axonal caliber. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Julien,et al.  Disruption of the NF-H Gene Increases Axonal Microtubule Content and Velocity of Neurofilament Transport: Relief of Axonopathy Resulting from the Toxin β,β′-Iminodipropionitrile , 1998, The Journal of cell biology.

[17]  W. Mushynski,et al.  Heterodimeric Associations between Neuronal Intermediate Filament Proteins* , 1997, The Journal of Biological Chemistry.

[18]  Hoh,et al.  Neurofilament‐L homopolymers are less mechanically stable than native neurofilaments , 1998, Journal of microscopy.

[19]  Mark Miller,et al.  Reassembly of the 66 kD neurofilament protein in vitro following isolation and purification from bovine spinal cord , 1995, Journal of neuroscience research.

[20]  W. Strittmatter,et al.  Expanded Polyglutamine Domain Proteins Bind Neurofilament and Alter the Neurofilament Network , 1999, Experimental Neurology.

[21]  D. Silberg,et al.  Mutation in Neurofilament Transgene Implicates RNA Processing in the Pathogenesis of Neurodegenerative Disease , 1999, The Journal of Neuroscience.

[22]  Jimi Adu,et al.  Persyn, a member of the synuclein family, influences neurofilament network integrity , 1998, Nature Neuroscience.

[23]  J. Julien,et al.  No requirement of α-internexin for nervous system development and for radial growth of axons , 1999 .

[24]  T. Shea,et al.  Neurofilament subunits can undergo axonal transport without incorporation into Triton-insoluble structures. , 1998, Cell motility and the cytoskeleton.

[25]  J. Julien,et al.  Interactions between peripherin and neurofilaments in cultured cells: disruption of peripherin assembly by the NF-M and NF-H subunits. , 1999, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[26]  V. Meininger,et al.  Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. , 1994, Human molecular genetics.

[27]  Bin Zhang,et al.  Requirement of Heavy Neurofilament Subunit in the Development of Axons with Large Calibers , 1998, The Journal of cell biology.

[28]  A Al-Chalabi,et al.  Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. , 1999, Human molecular genetics.

[29]  D. Cleveland,et al.  Slowing of axonal transport is a very early event in the toxicity of ALS–linked SOD1 mutants to motor neurons , 1999 .

[30]  Q. Zhu,et al.  Disruption of Type IV Intermediate Filament Network in Mice Lacking the Neurofilament Medium and Heavy Subunits , 1999, Journal of neurochemistry.

[31]  J. Julien,et al.  Transgenic Mice in the Study of ALS: The Role of Neurofilaments , 1998, Brain pathology.

[32]  L. Bruijn,et al.  Sequence variants in human neurofilament proteins: Absence of linkage to familial amyotrophic lateral sclerosis , 1996, Annals of neurology.

[33]  R. Liem,et al.  Overexpression of α-Internexin Causes Abnormal Neurofilamentous Accumulations and Motor Coordination Deficits in Transgenic Mice , 1999, The Journal of Neuroscience.

[34]  M. Schwartz,et al.  Characterization of Ribonucleoprotein Complexes and Their Binding Sites on the Neurofilament Light Subunit mRNA* , 1998, The Journal of Biological Chemistry.

[35]  Veeranna,et al.  Mitogen-Activated Protein Kinases (Erk1,2) Phosphorylate Lys-Ser-Pro (KSP) Repeats in Neurofilament Proteins NF-H and NF-M , 1998, The Journal of Neuroscience.

[36]  Akira Taniguchi,et al.  Advanced Glycation Endproducts in Neurofilament Conglomeration of Motoneurons in Familial and Sporadic Amyotrophic Lateral Sclerosis , 1998, Molecular medicine.

[37]  J. Julien,et al.  Delayed Maturation of Regenerating Myelinated Axons in Mice Lacking Neurofilaments , 1997, Experimental Neurology.

[38]  M. Somerville,et al.  Neurofilament Light and Polyadenylated mRNA Levels Are Decreased in Amyotrophic Lateral Sclerosis Motor Neurons , 1994, Journal of neuropathology and experimental neurology.

[39]  Elaine Fuchs,et al.  Integrators of the Cytoskeleton that Stabilize Microtubules , 1999, Cell.

[40]  R. Liem,et al.  The Intermediate Filament Protein Peripherin Is the Specific Interaction Partner of Mouse BPAG1-n (Dystonin) in Neurons , 1999, The Journal of cell biology.

[41]  Scott T. Brady,et al.  Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells , 1992, Cell.

[42]  Q. Zhu,et al.  Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  T. Crawford,et al.  Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport , 1996, The Journal of cell biology.

[44]  R. Huganir,et al.  Splice Variant-Specific Interaction of the NMDA Receptor Subunit NR1 with Neuronal Intermediate Filaments , 1998, The Journal of Neuroscience.

[45]  L. Descarries,et al.  Severe neuronal losses with age in the parietal cortex and ventrobasal thalamus of mice transgenic for the human NF‐L neurofilament protein , 1999, The Journal of comparative neurology.

[46]  J. Slade,et al.  Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS) , 1998, Neuroreport.

[47]  G. Rouleau,et al.  Analysis of the KSP repeat of the neurofilament heavy subunit in familial amyotrophic lateral sclerosis , 1996, Neurology.

[48]  M. Strong,et al.  Nitration of the low molecular weight neurofilament is equivalent in sporadic amyotrophic lateral sclerosis and control cervical spinal cord. , 1998, Biochemical and biophysical research communications.

[49]  T. Crawford,et al.  Neurofilament-dependent Radial Growth of Motor Axons and Axonal Organization of Neurofilaments Does Not Require the Neurofilament Heavy Subunit (NF-H) or Its Phosphorylation , 1998, The Journal of cell biology.

[50]  B. Giasson,et al.  Aberrant Stress-induced Phosphorylation of Perikaryal Neurofilaments* , 1996, The Journal of Biological Chemistry.

[51]  D. Figlewicz,et al.  Glutamate Potentiates the Toxicity of Mutant Cu/Zn-Superoxide Dismutase in Motor Neurons by Postsynaptic Calcium-Dependent Mechanisms , 1998, The Journal of Neuroscience.